Aimin Lin
Impact in
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
- Molecular Biology top 10%
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
Papers in
-
- Endometriosis Research and Treatment 2
- Co-authors
- Yue-Wei Qian (3 shared papers)Mariam E. Ehsani (2 shared papers)Robert J. Schmidt (2 shared papers)Guoqing Cao (2 shared papers)Robert J. Konrad (2 shared papers)Xiliang Wang (2 shared papers)Youyan Zhang (2 shared papers)Patrick I. Eacho (1 shared paper)
- Journals
- DNA and Cell Biology (1 paper)The Journal of Maternal-Fetal & Neonatal Medicine (1 paper)AIP Advances (1 paper)Frontiers in Oncology (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- United StatesChinaSingapore
In The Last Decade
Aimin Lin
10 papers receiving 1.4k citations
Aimin Lin's Hit Papers
Peers
Comparison fields: 5 of 84
- Cancer Research 179
- Molecular Biology 852
- Genetics 112
- Oncology 252
- Reproductive Medicine 67
Countries citing papers authored by Aimin Lin
This map shows the geographic impact of Aimin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aimin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aimin Lin more than expected).
Fields of papers citing papers by Aimin Lin
This network shows the impact of papers produced by Aimin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aimin Lin. The network helps show where Aimin Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Aimin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A transforming mutation in the pleckstrin homology domain of AKT1 in cancer Hit paper breakdown → | 2007 | 1074 |
| 2 | 2007 | 203 | |
| 3 | 2023 | 37 | |
| 4 | 2016 | 20 | |
| 5 | 2007 | 16 | |
| 6 | 2022 | 12 | |
| 7 | 2007 | 7 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 4 | |
| 10 | 2006 | 3 |
About Aimin Lin
Aimin Lin is a scholar working on Obstetrics and Gynecology, Reproductive Medicine, Immunology, Molecular Biology and Surgery, having authored 10 papers that have together received 1.4k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (2 papers), Biochemical and Molecular Research (2 papers), Endometriosis Research and Treatment (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Reproductive System and Pregnancy (2 papers), Tissue Engineering and Regenerative Medicine (1 paper), Glycosylation and Glycoproteins Research (1 paper) and RNA modifications and cancer (1 paper). The work is most often cited by research in Cancer Research (179 citations), Molecular Biology (852 citations), Genetics (112 citations), Oncology (252 citations) and Reproductive Medicine (67 citations). Aimin Lin has collaborated with scholars based in United States, China and Singapore. Frequent co-authors include Yue-Wei Qian, Mariam E. Ehsani, Robert J. Schmidt, Guoqing Cao, Robert J. Konrad, Xiliang Wang, Youyan Zhang, Patrick I. Eacho, Shaoyou Chu and Deshun Lu. Their work appears in journals such as DNA and Cell Biology, The Journal of Maternal-Fetal & Neonatal Medicine, AIP Advances, Frontiers in Oncology and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.